Core Efficacy

Blood Sugar Reduction: Simultaneously activates three metabolism-related receptors—GLP-1, GIP, and GCG—to synergistically promote insulin secretion, inhibit glucagon release, and delay gastric emptying, effectively lowering fasting blood glucose, postprandial blood glucose, and glycated hemoglobin levels.

Weight Loss: Triple receptor activation leads to stronger appetite suppression and a feeling of fullness, reducing calorie intake while promoting fat breakdown and improving energy metabolism, resulting in significantly greater weight loss than single- or dual-receptor agonists.

Metabolic Improvement: During weight loss, it can simultaneously reduce body fat percentage and waist circumference, help improve insulin resistance, and has potential ameliorative effects on obesity-related metabolic abnormalities such as hyperlipidemia and hypertension.